← Back to Search

Erector spinae plane catheter with 0.5% Ropivacaine for Mitral Valve Regurgitation

N/A
Waitlist Available
Led By Wilson Cui, MD, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 hours
Awards & highlights

Study Summary

This study is evaluating whether a local anesthetic injection may help reduce pain and other complications following minimally invasive mitral valve surgery.

Eligible Conditions
  • Mitral Valve Regurgitation
  • Mitral Valve Prolapse

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Total opiate consumption
Secondary outcome measures
Length of hospital stay
Length of intensive care stay
Pain score
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ESP + CryoablationExperimental Treatment1 Intervention
2. Cryoablation of intercostal nerves + ESP catheter with local anesthetic infusion.
Group II: CryoablationPlacebo Group1 Intervention
1. Cryoablation of intercostal nerves + Sham ESP catheter with saline infusion.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,505 Total Patients Enrolled
Wilson Cui, MD, PhDPrincipal InvestigatorUniversity of California, San Francisco

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~12 spots leftby Apr 2025